BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 45 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,426,891 | -49.3% | 1,347,000 | -50.9% | 0.00% | 0.0% |
Q3 2021 | $2,816,000 | +363.9% | 2,741,000 | +356.8% | 0.00% | – |
Q1 2021 | $607,000 | -91.2% | 600,000 | -90.6% | 0.00% | -100.0% |
Q4 2020 | $6,864,000 | +66.7% | 6,396,000 | +63.0% | 0.00% | 0.0% |
Q3 2020 | $4,118,000 | -30.5% | 3,924,000 | -19.0% | 0.00% | -25.0% |
Q2 2020 | $5,921,000 | +104.2% | 4,845,000 | +75.1% | 0.00% | +33.3% |
Q1 2020 | $2,900,000 | -28.2% | 2,767,000 | -27.6% | 0.00% | 0.0% |
Q4 2019 | $4,039,000 | +116.1% | 3,823,000 | +112.4% | 0.00% | +50.0% |
Q2 2019 | $1,869,000 | -41.1% | 1,800,000 | -41.9% | 0.00% | -33.3% |
Q1 2019 | $3,172,000 | -3.3% | 3,100,000 | -6.1% | 0.00% | 0.0% |
Q4 2018 | $3,281,000 | -51.1% | 3,300,000 | -47.6% | 0.00% | -50.0% |
Q3 2018 | $6,714,000 | +32.9% | 6,300,000 | +26.0% | 0.01% | +20.0% |
Q2 2018 | $5,051,000 | -12.7% | 5,000,000 | -18.9% | 0.01% | 0.0% |
Q1 2018 | $5,786,000 | +45.2% | 6,163,000 | +54.1% | 0.01% | +25.0% |
Q4 2017 | $3,985,000 | +22.2% | 4,000,000 | +24.2% | 0.00% | +33.3% |
Q3 2017 | $3,262,000 | – | 3,220,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SHENKMAN CAPITAL MANAGEMENT INC | 16,732,000 | $16,408,385 | 1.23% |
SONA ASSET MANAGEMENT (US) LLC | 23,125,000 | $22,451,923 | 0.93% |
SSI INVESTMENT MANAGEMENT LLC | 8,726,000 | $8,464,220 | 0.69% |
PFM Health Sciences, LP | 15,000,000 | $14,587,500 | 0.69% |
RWC Asset Management LLP | 10,000,000 | $9,709,000 | 0.63% |
Sonora Investment Management Group, LLC | 6,245,000 | $6,108,182 | 0.52% |
Paloma Partners Management Co | 10,006,000 | $9,733,285 | 0.34% |
MACKAY SHIELDS LLC | 9,891,000 | $9,594,270 | 0.26% |
PALISADE CAPITAL MANAGEMENT, LP | 8,704,000 | $8,455,066 | 0.24% |
Centiva Capital, LP | 10,000,000 | $9,716,288 | 0.21% |